Kristian Bernhard N.
- Country
- Norway
- Department
- N/A
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- A Comparative Study of Triamcinolone Acetonide and Triamcinolone Hexacetonide Injection Strategies Versus Surgical Intervention in Carpal Tunnel Syndrome
- Evaluation of Long-term Safety and Tolerability of TAK-861 in Patients with Narcolepsy Type 1
Data & Insights
Has run more than one trial at 22 of 63 partner sites.
Specializations
Sleep Medicine Specialization
Dedicated to advancing treatments for narcolepsy, with particular emphasis on Type 1 narcolepsy with cataplexy. The investigator focuses on understanding and managing excessive daytime sleepiness and related symptoms.
- Narcolepsy Type 1 Management
- Cataplexy Treatment Approaches
- Sleep-Wake Disorder Therapeutics
Investigates novel therapeutic approaches for sleep-wake cycle regulation and symptom control in narcolepsy patients.
Neurological Disorders
Specializes in evaluating innovative treatments for neurological sleep disorders, focusing on therapeutic interventions that target the underlying mechanisms of narcolepsy.
- Sleep-Wake Cycle Regulation
- Excessive Daytime Sleepiness
- Neurological Treatment Assessment
Examines long-term safety and efficacy profiles of emerging therapeutic agents in sleep medicine.
Clinical Assessment
Expertise in evaluating treatment outcomes using specialized assessment tools including the Epworth Sleepiness Scale for measuring daytime sleepiness in narcolepsy patients.
- Treatment Efficacy Evaluation
- Safety Profile Assessment
- Long-term Therapeutic Monitoring
Focuses on comprehensive evaluation of therapeutic interventions for sleep disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.